Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NexGen Diagnostics is a leading molecular diagnostic and genomics company based in India, specializing in high-throughput testing and advanced genetic analysis. The company provides a comprehensive suite of services including Next Generation Sequencing (NGS), Non-Invasive Prenatal Testing (NIPT), and specialized molecular assays for oncology and infectious diseases. NexGen Diagnostics operates as a strategic partner for global life science leaders, offering both clinical diagnostic services and research support for pharmaceutical and biotechnology organizations. Their business model focuses on integrating cutting-edge technology with clinical expertise to deliver precision medicine solutions across South Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NexGen Diagnostics.